Harnessing the power of T cells.
Profile Provided By: Company Website
Genocea finds targets of T cell responses to discover and develop life changing medicines.We ve created a pipeline of novel vaccine and immunotherapy programs that stimulate the T cell arm of the immune system which is increasingly recognized as critical to generating protective immune responses against a wide array of diseases.Genocea's pipeline of novel T cell vaccines includes GEN 003 for HSV 2 therapy and GEN 004 a protein vaccine directed at pneumococcus both currently in Phase II clinical trials.
|Human health & social work||C Corporation||Operating||51 - 200 employees|
Funding and Financing Rounds
Series C + / Equity
- Social Policies and Performance
Impact Reports & Metrics
100 Acorn Park Drive Floor 5
Cambridge, Massachusetts 02140
United States of America